Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRC Autologous Bone Marrow Cells for the Treatment of Appendicular Skeletal Fracture Non-Union

NCT00424567 is registered in ClinicalTrials.gov with Vericel Corporation as lead sponsor.

NCT NCT00424567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00424567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRC Autologous Bone Marrow Cells for the Treatment of Appendicular Skeletal Fracture Non-Union
Lead sponsor
Vericel Corporation
Phase
Phase 1/2
Overall status
Terminated
Start date
October 31, 2003
Completion date
June 30, 2007
Enrollment
36
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

fracture, ununited, pseudarthrosis